Efficacy of moxidectin and an ivermectin-praziquantel combination against ascarids, strongyles, and tapeworms in Thoroughbred yearlings in field tests on a farm in Central Kentucky in 2016.
Abstract: Field tests were performed on Thoroughbred yearlings (n=143), evaluating efficacy of moxidectin (MOX) against ascarids and strongyles and the efficacy of an ivermectin (IVM)-praziquantel (PRAZ) combination against those nematodes and tapeworms on a farm in Central Kentucky. The study was started on March 1, 2016 and completed on August 23, 2016. Fecal samples were collected from yearlings every two weeks for counts of ascarid and strongyle eggs per gram of feces (EPGs) and for determining the presence of tapeworm eggs. MOX was given to 88 yearlings on March 1; 55 yearlings were nontreated controls on this date but were treated two weeks later with MOX. On June 15, 2016, all yearlings (n=87) remaining on the farm were treated with IVM-PRAZ combination. Ascarids were present in low numbers for MOX-treated horses, and the drug had virtually no effect. The low number of ascarid infected horses before any treatment during the study was most likely due to age related immunity. Efficacy against strongyles was alike for both MOX and the IVM- PRAZ combination. At two weeks post-treatment, strongyle EPG values were reduced over 90%, started increasing at four weeks post-treatment, and returned to near pre-treatment values at six weeks post-treatment. Tapeworm efficacy of the IVM-PRAZ treatment was 96% at two weeks and was maintained for the entire ten-week post-treatment examination period.
Copyright © 2017 Elsevier B.V. All rights reserved.
Publication Date: 2017-03-20 PubMed ID: 31014628DOI: 10.1016/j.vprsr.2017.03.006Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research study is an investigation into the efficiency of moxidectin (MOX) and a ivermectin-praziquantel (IVM-PRAZ) combination in treating ascarids, strongyles, and tapeworms in Thoroughbred yearling horses, with field tests conducted on a farm in Central Kentucky in 2016.
Study Background
- The study was carried out on a farm in Central Kentucky, where 143 Thoroughbred yearlings were subjected to the field tests. The tests aimed to evaluate the performance of two drugs, MOX and an IVM-PRAZ combination, in eradicating ascarids, strongyles, and tapeworms.
Methodology
- The study was initiated on March 1st, 2016 and concluded on August 23rd, 2016.
- Fecal samples were collected from the yearlings every two weeks to determine the Egg Per Gram (EPG) count of ascarid and strongyle eggs and to identify the presence of tapeworm eggs.
- MOX was administered to 88 yearlings on March 1st, while 55 yearlings were treated two weeks later.
- All the yearlings remaining on the farm (n=87) received the IVM-PRAZ combination on June 15th, 2016.
Findings
- A low number of ascarids were found in horses treated with MOX, indicating that the drug had minimal effect on this type of parasite. The researchers suggest that the low prevalence of ascarids prior to treatment could be attributed to age-related immunity in the horses.
- Both MOX and the IVM-PRAZ combination had similar efficacy rates against strongyles. It was observed that strongyle EPG values were reduced over 90% two weeks post-treatment, started rising again at four weeks, and returned almost back to pre-treatment levels at six weeks post-treatment.
- IVM-PRAZ demonstrated 96% efficacy against tapeworms two weeks post-treatment, and this level of effectiveness was maintained throughout the ten-week post-treatment examination period.
Conclusion
- The study provides valuable insights into the effectiveness of MOX and an IVM-PRAZ combination against ascarids, strongyles, and tapeworms in horses. While MOX showed considerable effectiveness against strongyles, it was less effective against ascarids. The IVM-PRAZ combination maintained a high level of effectiveness against strongyles and tapeworms during the study period.
Cite This Article
APA
Lyons ET, Bellaw JL, Dorton AR, Tolliver SC.
(2017).
Efficacy of moxidectin and an ivermectin-praziquantel combination against ascarids, strongyles, and tapeworms in Thoroughbred yearlings in field tests on a farm in Central Kentucky in 2016.
Vet Parasitol Reg Stud Reports, 8, 123-126.
https://doi.org/10.1016/j.vprsr.2017.03.006 Publication
Researcher Affiliations
- Department of Veterinary Science, University of Kentucky, Gluck Equine Research Center, Lexington, KY 40546-0099, USA. Electronic address: elyons1@uky.edu.
- Department of Veterinary Science, University of Kentucky, Gluck Equine Research Center, Lexington, KY 40546-0099, USA.
- Private Equine Veterinary Practitioner, Versailles, KY, USA.
- Department of Veterinary Science, University of Kentucky, Gluck Equine Research Center, Lexington, KY 40546-0099, USA.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
